The application of next generation sequencing (NGS) on breast cancer has been associated with tremendous advances in the understanding of the disease. NGS can assist with screening for familial predisposition and can identify pathogenic sequence variants (mutations) that have an important predictive role in the implementation of targeted therapy.... Read more
The Oncomine Comprehensive Assay Plus (OCAPLUS) is a Next Generation Sequencing (NGS) test that allows for extensive solid tumour genomic profiling based on the analysis of more than 500 genes, including mutations, fusions, and copy number variations (CNVs).... Read more
Endometrial carcinoma (EC) is the 5th most common cancer affecting women in South Africa.... Read more
Hepatobiliary, ampullary and pancreatic carcinomas are a group of aggressive malignancies that arise in the liver, bile ducts, gallbladder, and pancreas.... Read more
Colorectal cancer is among the top three cancers for both men and women in South Africa. Genetic testing plays an integral part in the prognostication, germline screening, and management of colorectal carcinoma.... Read more
Breast carcinoma is the most commonly diagnosed cancer among women in South Africa and a leading cause of cancer-related mortality.... Read more